Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Mon 30 May 2005, 17:05 Moulmed - Reviewed preliminary results for the yea
Moulmed - Reviewed preliminary results for the year ended 28 February 2005      
Moulded Medical Supplies Limited                                                
(Incorporated in the Republic of South Africa)                                  
(Registration number 1995/003771/06)                                            
(Share code: MUM & ISIN code: ZAE000058731)                                     
REVIEWED PRELIMINARY RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2005                
GROUP INCOME STATEMENT                           Reviewed          Audited      
for the year ended 28 February 2005              12 Months         12 Months    
R000`s                                           Feb 05            Feb 04       
Revenue                                          5,900             2,433        
Cost of sales                                    3,967             1,318        
Gross profit                                     1,933             1,115        
Operating costs                                  1,832             (1,819)      
Operating profit (loss) from ordinary activities 101               (704)        
Loss from extraordinary activities               -                 (13,898)     
Capital items                                    -                 28           
Income / (loss) before investment income         101               (14,574)     
Investment income                                1                 11           
Net Income / (loss) before tax                   102               (14,563)     
Tax                                              -                 -            
Net income / (loss) after tax                    102               (14,563)     
Attributable to outside shareholders             (62)              7            
Net profit / (loss) for the year                 40                (14,556)     
Dividends                                        -                 -            
Accumulated income / (loss) for the year         40                (14,556)     
Accumulated income /(loss) beginning of year     (15,550)          (994)        
Accum. income / (loss) at the end of year        (15,510)          (15,550)     
Earnings per share                               0.04              (15.1)       
Headline earnings / (loss) per share             0.04              (0.7)        
Dividends per share                              0.0               0.0          
RECONCILIATION BETWEEN EARNINGS AND HEADLINE EARNINGS                           
Net Income / (loss) attributable to shareholders 40                (14,556)     
Loss of extraordinary activities                 -                 13,898       
Capital Items                                    -                 (28)         
Headline profit / (loss)                         40                (686)        
Shares issued - 000`s                            96,260            96,260       
Headline profit / (loss) per share (cents)       0.04              (0.7)        
STATEMENT OF CHANGES IN EQUITY                                                  
Ordinary shareholders` funds - begin             (1,840)           12,716       
Movement in retained earnings                    40                (14,556)     
Ordinary shareholders` funds - end               (1,800)           (1,840)      
GROUP BALANCE SHEET                              Reviewed          Audited      
at 28 February 2005                              12 Months         12 Months    
R000`s                                           Feb `05           Feb `04      
ASSETS                                                                          
Non-current assets                               4                 2            
Fixed assets                                     4                 2            
Intangibles                                      -                 -            
Deposits                                         -                 -            
Investments and loans                            -                 -            
Current assets                                   2,662             1,613        
Inventory                                        821               1,105        
Trade and other receivables                      1,531             498          
Bank balances and cash                           310               10           
TOTAL ASSETS                                     2,666             1,615        
EQUITY AND LIABILITIES                                                          
Capital and reserves                             (1,800)           (1,840)      
Share capital                                    13,710            13,710       
Reserves                                         (15,510)          (15,550)     
Minority interest                                (551)             (613)        
Non-current liabilities                          920               1,088        
Long term liabilities                            920               1,088        
Current liabilities                              4,097             2,980        
Trade and other payables                         3,835             2,672        
Provision for income tax                         262               308          
TOTAL EQUITY AND LIABILITIES                     2,666             1,615        
Number of shares in issue - 000`s                96,260            96,260       
UNAUDITED CASH FLOW STATEMENT                                                   
Net cash inflow / (outflow) from operations      472               (11,548)     
Net (outflow) / inflow - investing activities    (4)               11,398       
Net cash inflow / (outflow) - financing          (168)             117          
activities                                                                      
Net cash (outflow) / inflow from activities      300               (33)         
CASH AND CASH EQUIVALENTS AT                     10                43           
BEGINNING                                                                       
CASH AND CASH EQUIVALENTS AT                     310               10           
END                                                                             
COMMENTS                                                                        
The company and its subsidiaries have achieved the following milestones.  Rest  
and Recuperation Retreats Ltd (Medical and General Tourism) has successfully    
commenced with the selling of exclusive licenses.  Mouldmed Group has finalized 
negotiations with a suitable BEE partner - Nubian.  Mouldmed Group has through  
its subsidiary Rest and Recuperation Retreats Ltd finalized negotiations with   
Route +27 RD (Pty) Ltd the owners of the South African Tourism Encyclopaedia who
in turn have an agreement enabling all the information on the CD to be available
on the SMS services of Vodacom, MTN and Cell C (independent auditors valuation  
of the business potential is in excess of R300 million Rand).  Mouldmed Group   
has moved to new premises, which is able to accommodate all the activities of   
the group`s expansion.  The Group has a signed agreement of sale to take        
transfer of this building on or before November 2005.  Rest and Recuperation    
Retreats Ltd has finalized negotiations with a BEE partner - Tselane Basadi (Dr 
Namane Magau), which has resulted in them acquiring a 26% shareholding.         
REVIEW OF PRELIMINARY FINANCIAL RESULTS                                         
The immediate results, due to the lack of working capital are still             
disappointing but Management believes in a positive change in the financial year
28/02/2006.  Provided approval of the Circular is not delayed any further.  Such
approval will ensure the flow of the necessary working capital to realize the   
strategic plans of the company.                                                 
REVIEW                                                                          
The company`s auditors, PZ van der Merwe and Co have reviewed the preliminary   
financial results and expressed a qualified opinion with regard to the going    
concern consideration.  The auditor`s report is available for inspection at the 
company`s registered office.  The financial statements have been prepared in    
accordance with South African Statements of Generally Accepted Accounting       
Practice and are based on appropriate accounting policies, which have constantly
applied and which are supported by reasonable and prudent judgement and         
estimates.                                                                      
POST BALANCE SHEET EVENTS                                                       
Mouldmed Group is in the process of finalizing the negotiations of the Medical  
Exhibition Centre for international exhibitions and has organized two one-day   
seminars for such exhibitors to attend.  Mouldmed Products and Mouldmed Locum   
International Exchange are ready to follow in the steps of Rest and Recuperation
Retreats Ltd by licensing the companies locally. Rest and Recuperation Retreats 
Ltd are ready to launch the licensing program in the United Kingdom and Europe. 
ON BEHALF OF THE BOARD                                                          
DR S BRITS  (Chairman)                                                          
MR GERRIT A THERON (CEO)                                                        
30 MAY 2005
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: